PrEP4All sues federal government over 2025 HIV prevention research agreement Gay City News 4d Gay City News 4d HIV Biotech Pharma All sources
Gilead Sciences, Inc. (GILD) is attracting investor attention: Here is what you should know Zacks 6d Zacks 6d Gilead Sciences Inc GILD Pharma
Earnings to watch: Gilead Sciences (GILD) reports Q1 results tomorrow Barchart 16h Barchart 16h Pharma Biotechnology Wall Street All sources
Gilead’s pipeline strategy in 2026: A broadening focus beyond HIV Labiotech 14:07 Mon, 27 Apr Labiotech 14:07 Mon, 27 Apr HIV Biotech Pharma
What's going on with arcus biosciences stock on Wednesday? Benzinga 20:23 Wed, 22 Apr Benzinga 20:23 Wed, 22 Apr Pharma Article paywall
Lenacapavir and the long road from ‘miracle’ to global access Observer Research Foundation 11:36 Thu, 16 Apr Observer Research Foundation 11:36 Thu, 16 Apr AIDS WHO Doctors Without Borders
California's highest court leans toward Gilead in considering drugmakers' 'duty to innovate' The Charlotte Observer 20:36
California's highest court to consider whether drugmakers have 'duty to innovate' The Charlotte Observer 11:26
Clio Health Champions: Jenny Yun, Senior Director, U.S. HIV Prevention Marketing – Gilead Sciences Muse by Clio 13:51 Tue, 05 May
Use of Gilead's HIV prevention shot rises, but US insurance gaps remain The Tribune, California 11:30 Tue, 05 May
Curious about Gilead (GILD) Q1 Performance? Explore Wall Street Estimates for Key Metrics Zacks 15:21 Mon, 04 May
The “Duty to Innovate” Arrives at the California Supreme Court: Oral Argument Set for May 6, 2026 Drug & Device Law 10:03 Mon, 04 May
PrEP4All sues federal government over 2025 HIV prevention research agreement Gay City News 17:42 Sat, 02 May